Charles Lineberry

Dr. Lineberry has over 40 years of professional experience in biomedical research, including over 30 years in the pharmaceutical and biotechnology industries, and is currently Principal and Co-Founder of Sunrise Therapeutics, LLC, a clinical and regulatory pharmaceutical consulting firm. Previously, Dr. Lineberry was Co-founder and CEO of Lineberry Research Associates, LLC, a full-service CRO providing clinical and non-clinical drug development and regulatory operations management and strategic consulting services to the pharmaceutical industry. Prior to founding LRA, Dr. Lineberry was Senior Director, Clinical Neurosciences at Burroughs Wellcome Co., where he was responsible for the clinical development programs in psychiatry, neurology, and anesthesiology and supervised the successful submission of 18 INDs and 7 new drug approvals. Dr. Lineberry has a Ph.D. in physiological psychology, NIH post-doctoral training in neurobiology, and has held teaching and research positions in the medical schools at the University of Florida, the University of Pittsburgh, and the University of North Carolina.